Q220P5 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihvnnhc5qlj5liyr37jeai3jidv32mvxf547uz23zuffj5swf36ki/metadata.json
IPFS of structure file: 
bafybeib5kudec2h5gswjjve5nwlyhzjlindv2zkvfxvg2zmeybn3oeh3ri/AF-Q220P5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdf27c3fD9945ab234E04271Bf23AcF50Ec8f9f0E
First NFT owner address (bech32): 
genesis1munu8lvegk4jxnsyyudlywk02rkgl8cwpaxduf
Current NFT ID #450305 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
450305
Accession (UniProt):
Q220P5
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Rhodoferax ferrireducens (strain ATCC BAA-621 / DSM 15236 / T118)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q220P5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q220P5|SYL_RHOFT Leucine--tRNA ligase OS=Rhodoferax ferrireducens (strain ATCC BAA-621 / DSM 15236 / T118) OX=338969 GN=leuS PE=3 SV=1 MQEKYTPLDVEQAAQSHWTAMDAYRVTEDSSKKKFYACSMLPYPSGKLHMGHVRNYTINDMLTRYLRMNGYNVLMPMGWDAFGLPAENAALKNGVPPAQWTFENIAYMKQQMQAMGLAIDWSREVATCDPSYYKWNQWLFLKMLDKGIAYRKTQVVNWDPVDQTVLANEQVIDGKGWRTGATVEKREIPGYYLKITDYAEELLGQVQTGLPGWPERVKLMQENWIGKSEGVRFAFTHDIRDASGALIDDGRMYVFTTRPDTIKGVTFCAVAPEHPLALHAARGNPALAAFIEECKTGGTTEAELATQEKKGLDTGLIVTHPLTQLPVAVWVGNYVLMSYGDGAVMGVPAHDERDFAFAKKYGLPIKQVVQVDGEQFDYDQWQDWYADKQRGVAINSGSFSGMSFKQAVEAVAHKLAALGLGEKKTTWRLRDWGVSRQRYWGTPIPIIHCPEHGAVPVPEKDLPVVLPQDCVPDGSGNPLHKHEGFHAGVVCPICGVAARRETDTMDTFVDSSWYFMRYCDPKNEKAMVGEGAAYWMPMDQYIGGIEHAILHLLYARFWTKVMRDLGLVKVDEPFTKLLTQGMVLNHIYSRKGENGAKDYFWPNDVENVSDETGKVVAAKLKVAVGNLPAGTLVDYEGIGTMSKSKNNGVDPQDLIERYGADTARLYTMFTAPPEATLEWNDAAVEGSYRFLRRVWNFGIKLSTIDMIAVDESTTGATALNDINFSKEAKVLRLEIHTVLKQVDYDYQRMQYNTVVSGAMKMINALENFKATDSGGAQVALIEGFGILLRCLYPATPHIAHSLWQGLGYAGTLGDLLDAPWPQVDELALLQDEVELMLQINGKLRGAIVVSAGASKVEIELAAIDSEVFRKLANGATPKKVIVVPGRLVNLVV